Alterity Therapeutics

1 Follower


Alterity is developing first-in-class therapies to treat neurodegenerative disease.


Add photos to showcase Alterity Therapeutics’s culture


Add Alterity Therapeutics’s values

Insider experiences

Share your experience of working at Alterity Therapeutics

Jim Kerr
Vice President, CMC
Margaret Bradbury
VP, Nonclinical Development

Add your teams to show how people work together at Alterity Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.